Pharmacological Inhibition of Glutaminase 1 Normalized the Metabolic State and CD4+ T Cell Response in Sjogren’s Syndrome
Previous studies have shown that abnormal metabolic reprogramming in CD4+ T cells could explain the occurrence of several autoimmune disorders, including Sjogren’s syndrome (SS). However, therapeutic targets of the abnormal metabolism of CD4+ T cells remain to be explored. Here, we report that gluta...
Saved in:
Main Authors: | Jiayao Fu, Yiping Pu, Baoli Wang, Hui Li, Xiujuan Yang, Lisong Xie, Huan Shi, Zhijun Wang, Junhao Yin, Tianle Zhan, Yanxiong Shao, Changyu Chen, Qi Luo, Jiabao Xu, Zirui Zong, Xindi Wei, Wanwen Xiao, Chuangqi Yu, Lingyan Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2022/3210200 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Anti-proliferative Effect of a Novel Glutaminase Inhibitor IN-3 on Prostate Cancer Cells
by: Ummuhan DEMIR, et al.
Published: (2024-09-01) -
Contribution of Genetic Factors to Sjögren’s Syndrome and Sjögren’s Syndrome Related Lymphomagenesis
by: Adrianos Nezos, et al.
Published: (2015-01-01) -
Sjögren syndrome and lymphoma
by: Pedro Juan Barrios Fuentes, et al.
Published: (2018-08-01) -
The Characterization of L-Asparaginase with Low L-Glutaminase Activity Produced by the Marine <i>Pseudomonas</i> sp. Strain GH-W2b
by: Woon-Jong Yu, et al.
Published: (2024-12-01) -
Advances in Pathogenesis of Sjögren’s Syndrome
by: Yao Tian, et al.
Published: (2021-01-01)